Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-26

Clinical Trial Update: 5% Topical Ibuprofen (IBU) for Ankle Sprain [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating 5% topical ibuprofen for ankle sprains has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ibuprofen topical 5% (ibuprofen)

Snippet

Sponsor: Pfizer | Conditions: Ankle Injuries | Phase 3 | Status: COMPLETED | Results posted: 2016-05-26